American Pain Society's 27th Annual Scientific Meeting (May 8

105

The Role of Phosphorylation of PKC Kinase in Signaling Visceral Nociception in Spinal PSDC Pathway
Jing Wu, MD, PhD, Xuan Zhang, MD, PhD, Guangxiao Su, Yongzhong Lei, Haring Nauta, MD, PhD, Qing Lin, MD, PhD and Li Fang, MD, PhD

107

Biomarkers of Pain in Arthritis: A Study of Inflammatory arthritidies and Osteoarthritis
Jasvinder A. Singh, MD, MPH, Keith Knutson, PhD and Sherine Gabriel

109

Effects of age on thermal sensitivity in the rat
Robert Yezierski, PhD, Christy Carter, PhD, Christopher King, Drake Morgan, PhD and Charles Vierck, PhD

111

Role of P2X receptors in colon hypersensitivity in the mouse
Masamichi Shinoda, DDS, Eiji Ohtsuka and G.F. Gebhart

113

Pregabalin attenuates mechanical and cold allodynia in Zucker diabetic fatty rats
Shelley Dima, Mark O. Urban and Eric D. Crown

115

Involvement of sex hormones in a mice model of neuropathic pain
Patricia Robichaud, Marie-France Spooner, Julie Carrier and Serge Marchand

117

Peroxisome proliferator-activated receptor-gamma activation reverses existing hypersensitivity in diabetic neuropathic rats: Possible mechanisms
Satyanarayana S.V. Padi, MPharm, PhD, Jatinderjot K. Kehal, Seema Thakur and Saurabh Sharma

119

Behavioral and anatomical characterisation of a novel model of neuropathic pain: Bilateral chronic constriction injury in rats
Sukdeb Datta, MD, Koel Chatterjee, PhD, Robert Kline, MS and Ronald Wiley, MD, PhD

121

CG100649, a novel dual-acting COX-2 and carbonic anhydrase inhibitor: Preclinical safety evaluations
Cheol Soon Lee, PhD, Jun Yong Yang, MS, Sun Kyung Kang, MS, Hyun Sil Seo, MS, Cheol Min Kim, PhD, Sun Nam Kim, PhD, Myung Guan Park, PhD, Ho-Jin Chang, PhD, William Schmidt, PhD, Joong Myung Cho, PhD and Seonggu Ro, PhD

123

Vibration exposure induces mechanical hyperalgesia in lean but not fatty Zucker rats
Kristine Krajnak, PhD, Claud Johnson, Stacey Waugh and Roger Miller

125

Microinjection of hypocretin-1 into the pontine reticular nucleus, oral part (PnO) of Sprague-Dawley rat decreases response to nociceptive input
Sarah L. Watson, Christopher J. Watson, PhD, Helen A. Baghdoyan, PhD and Ralph Lydic, PhD

127

Decreased nociceptive sensitization in mice lacking the fragile X mental retardation protein: role of mGluR1/5 and mTOR
Theodore J. Price, PhD, Md Rashid, Magali Millecamps, Raul Sanoja, Jose Entrena and Fernando Cervero

129

What is the role of age and sex hormones in pain perception during menopause
Yannick Tousignant-Laflamme, PhD(c), Kathya Daigle and Serge Marchand, PhD

131

Psychophysiological predictors of subjective ratings of electrodermal stimuli: The contribution of spinal and supraspinal reflexes
Emily J. Bartley, MS, Fred Kurzban, Jennifer L. Russell, MA, Amy E. Williams, MA, Klanci M. McCabe, MA and Jamie L. Rhudy, PhD

133

The relation of stress and heart rate variability to placebo analgesia
Per M. Aslaksen, Cand, Psychol and Magne Flaten

135

Differential engagement and functioning of visceral- and somatic-specific pain networks in irritable bowel syndrome, irritable bowel syndrome with fibromyalgia, and healthy controls
Jennifer Labus, PhD, Bruce D Naliboff, Lin Chang, Steve M Berman, Brandall Suyenobu, Mark Mandelkern, MD, PhD and Emeran A Mayer

137

Cellular localization of inflammatory pain signaling in spinal cord dorsal horn
Amanda R. Weyerbacher, Cristina Tamasdan, Qinghao Xu, Hsinlin Thomas Cheng and Charles E. Inturrisi

139

Mechanisms of Placebo Analgesia: fMRI identifies sustained and transient regional involvement
Jason G. Craggs, PhD, Donald D. Price, PhD, William M. Perlstein, PhD and Michael E. Robinson, PhD

141

Anxiety-proneness modulates pain-induced brain activation: Insights from an independent component analysis (ICA)
Morten S. Hadsel, DDS, Alexandre Quevedo, DDS, PhD, Yoshitetsu Oshiro, MD, PhD, Robert A. Kraft, PhD and Robert C. Coghill, PhD

143

Blockade of NMDA receptors in the RVM reverses hyperalgesia in chronic muscle pain
Josimari M. De Santana, PT, PhD and Kathleen A. Sluka, PT, PhD

145

Cognitive modulation of radiation of pain
Alexandre Quevedo, DDS, PhD and Robert C. Coghill, PhD

147

Assessment of preserved sympathetic cholinergic response and chronic pain in Brown Sequard syndrome: Case study
Arzhang Zereshki, MD, Geke van der Ende, MS and R. Norman Harden, MD

149

Reduced cold hyperalgesia, allodynia and anatomic effects of lumbar intrathecal NPY-saporin
Ronald G. Wiley, MD, PhD, Robert Kline, IV and Laurie Lemons

151

Pharmacological and non-pharmacological strategies for preventing analgesic tolerance to TENS
Josimari M. De Santana, PT, PhD and Kathleen Sluka, PT, PhD

153

Relations between objective sleep data, sleep disorders, and signs and symptoms of temporomandibular joint disorder (TMD)
Emerson Wickwire, PhD, Kristine Bellinger, Tarek Kronfli, Edward, G. Grace, DDS, Eleni Sarlani, DSS, Katherine Wang, Luis Buenaver and Michael Smith

157

Physical activity and augmented brain responses to pain in fibromyalgia
Michael J. McLoughlin, BA, Laura D. Ellingson, MS, Aaron J. Stegner, PhD and Dane B. Cook, PhD

159

Baseline heart rate variability predicts increased pain after sleep restriction in healthy adults
Jennifer M. Glass, PhD, Angela Lyden, Kirsten Ambrose, Kimberly Groner, Richard Gracely, David Williams and Daniel Clauw

161

A comparison between electronic diaries and paper-based pain assessment in individuals with fibromyalgia (FM)
David Williams, PhD, R. Michael Gendreau, MD, PhD and Daniel Clauw, MD

163

Medical care and APS guideline-related prescription drug use in newly diagnosed and established Fibromyalgia patients
Leigh Ann White, PhD, Howard Birnbaum, PhD, Anna Kaltenboeck, MA, Seth Samuels, David Mallett, MA and Rebecca Robinson, MS

165

Emotional factors in the onset and aggravation of Fibromyalgia symptoms: Results of an internet survey
Hilary D. Wilson, PhD, James P. Robinson, MD, PhD, Kimberly S. Swanson, PhD and Dennis C. Turk, PhD

167

The effectiveness of three psychological therapies in the rehabilitation of Fibromyalgia patients: A randomized controlled trial
Kimberly S. Swanson, PhD, Hilary Wilson, PhD, James P. Robinson, MD, PhD and Dennis C. Turk, PhD

169

Proinflammatory Cytokine Profiles Associated with TMD Case Status and Related Intermediate Phenotypes
Mathew Conrad, Rebecca Arunasalam, Dustin Gibson, Eric Bair, Shad Smith, Gary D. Slade, PhD, William Maixner, PhD, DDS, Luda Diatchenko, PhD and Andrea G. Nackley, PhD

171

Stress-related thyroxine release and delayed episodic pain flares in a patient with complex regional pain syndrome
Roger J. Allen, PhD, PT and Chad McCann, SPT

173

Cognition-induced increases in IL-6 (via pain catastrophizing) are not mediated by cortisol
Beth Darnall, PhD, Heather Zwickey, PhD and William Gregory, PhD

175

Acculturation and oral pain among Hispanics
Erica Gibson, PhD, Evelyn Ortiz and Joseph Riley

177

Attributes of pain in young children with sickle cell disease
Beth Ely, RN, PhD, Carlton Dampier, MD, Darcy Brodecki, BS and Patricia O'Neal, BS

179

TENS modifies gastric myoelectrical activity, pain scores and plasma VIP, motilin and IL-6 levels in systemic sclerosis
Terry A. McNearney, MD, Hanaa Sallam, MD, Dipti Doshi, MBBS, Sonya E. Hunnicutt, MS, MA and Jiande Chen, PhD

181

Psychological impairment influences pain duration following surgical injury
Ian Carroll, MD, MS, Jen Wang, Charlie Wang, Matthew Gillespie, Peter Barelka, Keith Humphreys, PhD, Jodie Trafton, PhD, Frederick Dirbas, MD, Stuart Goodman, MD, Richard Whyte, MD, Walter Cannon, MD, George Yang, MD, John Pollard, MD and Sean Mackey, MD, PhD

183

Evaluation of Lacosamide in diabetic neuropathic pain trials
Aziz Shaibani, MD, FACP, Sabine Bongardt, MS and Ken Sommerville

185

A comparison of strategies for switching patients from amitriptyline to duloxetine for the management of diabetic peripheral neuropathic pain
Michael J. Robinson, MD, Virgil Whitmyer, Richard Risser, Sandra Malcolm and Jonna Ahl

187

A randomized pharmacokinetic study of AD 923 (Fentanyl Sublingual Spray) vs. Actiq® (OTFC) and Fentanyl Citrate injection in healthy human volunteers
Robert Tansley, MD, Sandra Connolly, MD, Robin Bannister, PhD, Bharat Ruparelia, Sue Snape, PhD, Ian Walker, PhD and Ali Raza, MD

189

Rapid and effective control of breakthrough pain (BTP) and tolerability in cancer patients treated with BEMA^TM(BioErodible MucoAdhesive) Fentanyl
James M. North, MD, Rohit Kapoor, Janet Bull, William Reid and Andrew Finn

191

Dose linearity and absolute bioavailability of BEMA^TM(BioErodible MucoAdhesive) Fentanyl in healthy volunteers
Niraj Vasisht, Jeffrey Stark and Andrew Finn

193

Concurrent use of Ketamine and Methadone in severe cancer pain
Damian J. Martino, MD, Cristina Tamasdan, MD, Natalie Moryl, MD and Charles Inturrisi, PhD

195

A longitudinal examination of cancer pain: Severity, characteristics, and impact on quality of life
Carmen R. Green, MD and Tamera Hart-Johnson, MS

197

Short Term Effects of 2-grams of Dietary Ginger on Muscle Pain, Inflammation and Disability Induced by Eccentric Exercise
Christopher D. Black and Patrick J. O'Connor

199

Consider the Choices
Fabienne M. Jones

201

Continuous block of the brachial plexus through infra-clavicular approach in CRPS type II of the upper extremity
Mohammad Maroof, MD, Obaid Ahmed, MBBS, Hammad Usmani, Rashid Khan, Muneeb Ahmed and Sameer Maroof

203

Slow-frequency Prefrontal rTMS for Refractory Neuropathic Pain
Paola Sandroni, MD, PhD, Simon P Kung, Donald E McAlpine and Shirlene Sampson

205

Double-blind, placebo-controlled studies of carisoprodol 250-mg tablets in the treatment of acute lower back spasm
Lee Ralph, MD, Michelle Look, MD, Gregory Serfer, DO and Harry Sacks, MD

207

Managing Chronic Pain with Low Dose of Nabilone
Mona Man Yee Lee, MD, CCFP

209

Neurotrophin-Drug Conjugates: Targeting Glucocorticoids to Treat Focal Pain
Robert R. Webb, Constance A. McKee, G. Craig Hill, Robert B. Campenot, Robert G. Dalziel and Steven B. Kahl

211

CB2 agonists reduce carrageenan-induced thermal hyperalgesia and edema in mice via a non-CB2 receptor mechanism
Sonya G. Lehto, PhD, Wenhong Guo, Annika B. Malmberg, Ming Huang, Yuan Cheng, Susan Tomlinson, Erin DiMauro, Renee Emkey, Liyue Huang, Ella Magal, Jean-Claude Louis, Stephen A. Hitchcock, Vinod Patel and Robert T. Fremeau

213

Low-dose intrathecal naloxone to enhance intrathecal morphine analgesia in the treatment of refractory severe chronic low back pain
Scott Hamann, MD, William Witt and Paul A. Sloan, MD

219

Intramuscular (IM) ketamine for treating headache and pain flare-ups in the clinic
John Claude Krusz, PhD, MD, Jane Cagle, LVN and Stephanie K. Hall, BS, MPH

221

Efficay of IV lidocaine to treat pain and headache flare-ups in the outpatient clinic
John Claude Krusz, PhD, MD, John Claude Krusz, PhD, MD, Stephanie K. Hall, BS, MPH, Diane Cammarata, APRN, BC and Jane Cagle, LVN

223

Evidence for a combined mode of action underlying the broad efficacy profile of tapentadol, a novel centrally acting analgesic
Gregor Bahrenberg, Jean De Vry, Thomas Christoph, Babette Kögel, Klaus Schiene, Werner Englberger, Thomas I. F. H. Cremers and Thomas M. Tzschentke

225

The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial
Mark A. Ware, MBBS, MRCP, MSc, Mary-Ann Fitzcharles, MD and Yoram Shir, MD

227

Efficacy profile of tapentadol, a novel centrally active analgesic with a combined mode of action, in animal pain models
Thomas M. Tzschentke, Thomas Christoph, Murielle Méen, Babette Kögel, Klaus Schiene and Jean De Vry

229

Efficacy of tapentadol immediate release in patients with pain after bunionectomy
Charles Oh, David Upmalis, Akiko Okamoto, Y.-W. Ma, Jens-Ulrich Stegmann and S. Daniels

231

Analgesic onset of a novel liquid-gel formulation of diclofenac potassium in post surgical dental pain
William Schmidt, PhD, Demi Niforos, MS and Stephen Boesing, MS

233

Treatment of NSAIDS and foot orthoses relieving musculoskeletal foot pain caused by chemical neurolysis in post stroke patients
Parul Jajoo, Resident, Anthony Oreste, Lilia Vinarsky, Kevin Dunn and Yakov Raufov

235

Evaluation of abuse potential of ALO-01, an investigational abuse-deterrent extended-release morphine sulfate plus sequestered naltrexone formulation, among recreational opioid users
James B. Jones, MD, PharmD, Franklin Johnson, MS, George Wagner, BS, Joseph Stauffer, DO and Edward Sellers, MD, PhD

237

Effects of 12-hour extended-release hydrocodone/acetaminophen treatment in cytochrome P450 2D6 poor metabolizers
David A. Katz, Brian B. Spear, Anahita Bhathena, David R. Grimm, James W. Thomas, Chaohui Wang, Kenneth Idler, Rhonda Holley-Shanks, Sarah Abel, Toby Mueller, Earle Lockhart and Rita Jain

239

The Association of Digit Ratio with Butorphanol Analgesia in Humans
Margarete C. Ribeiro-Dasilva, DDS, PhD, Rene Shinal, Toni Glover, Teonia Burton, Wesley Gladin, Danielle Case, Roland Staud, MD and Roger B. Fillingim, PhD

241

Bioavailability of Oxymorphone extended-release tablets following consumption of alcohol or food
William D. Fiske, PhD, Irma H. Benedek and Harry Ahdieh

243

Comparative phase I PK study of Aerosolized free and Liposome-Encapsulated Fentanyl (AeroLEF™) demonstrates rapid and extended plasma fentanyl concentrations following inhalation
Orlando R. Hung, MD, FRCPC and Diana H. Pliura, PhD

245

Trends in opioid use for chronic non-cancer pain in Medicaid and private insurance plans 2000-2005: TROUP study
Mark D. Sullivan, MD, PhD, Ming-Yu Fan, Jennifer Braden, MD, MPH, Mark Edlund, MD, PhD, Bradley Martin and Andrea DeVries, PhD

247

Epidural anaesthesia with 0.5% bupivacaine alone or with sufentanil in lower limb orthopaedic surgery
Mohammad Maroof, MD, Obaid Ahmed, MBBS, Hammad Usmani, Ahmed Muneeb, Rashid Khan and Sameer Maroof

249

Assessment of disability level and sleep interference in moderate to severe chronic low-back pain patients treated with 12-hour extended-release hydrocodone/acetaminophen tablets: A phase-3 withdrawal trial
Christine Codding, Dale Levinsky, Martin Hale, James W. Thomas, Pamela Vo, Steven E Marx, Earle Lockhart and Rita Jain

251

Decrease of Cold Pain Tolerance Following Opioid Detoxification
Jarred Younger, PhD, Sara Parke, Peter Barelka, Ian Carroll, Larry Chu, Ravi Prasad, Ray Gaeta and Sean Mackey

253

Fentanyl buccal tablets effective for pediatric patient with episodic pain secondary to ulcerative colitis
Mark L. Holtsman, PharmD, Lana Wania-Galicia, MD and Dean Williamson, PharmD

255

A response profile for fentanyl buccal tablet (FBT) in opioid-tolerant patients with breakthrough pain (BTP)
John T. Farrar, MD, PhD, Edward Michna, MD, John Messina, PharmD and Fang Xie, PhD

257

The use of therapeutic drug monitoring and pharmacogenomics to follow chronic pain management patients: A case study during rreatment and following the unexpected death of a patient on methadone
Paul J. Jannetto, PhD and Nancy C. Bratanow, MD

259

Efficacy of Oxymorphone extended release in opioid-experienced patients with chronic low back pain due to a herniated disc: Subgroup analysis of a randomized, double-blind, placebo-controlled trial
Martin E. Hale, MD, Tina Ma, PhD, Harry Ahdieh and Rosemary Kerwin

261

Use of an implantable intrathecal morphine pump in the treatment of refractory pain caused by Thalamic Syndrome
Viji Shankar, MD, Abraham J. Kabazie, MD and Anissa Boyle, PA-C

263

Forget IV PCA; Perioperative multimodal oral analgesia for spine surgery
Sharad Rajpal, MD, Debra B. Gordon, RN, MS, FAAN, Teresa A. Pellino, RN, PhD, Andrea L. Strayer, NP, MS, CNRN, Gregory R. Trost, MD, Thomas A. Zdeblick, MD and Daniel K. Resnick, MD

265

A randomized controlled trial demonstrates the efficacy, safety and tolerability of Aerosolized free and Liposome-Encapsulated Fentanyl (AeroLEF™) via pulmonary administration
Richard T. Brull, MD, FRCPC and Vincent W.S. Chan, MD, FRCPC

267

Effectiveness of aerosolized intraperitoneal bupivacaine in reducing post-operative pain in pediatric patients undergoing laparoscopic surgery
Drew A. Freilich, Constance S. Houck, MD, Petra M. Meier, MD, Carlo Passerotti, MD, Alan B. Retik, MD and Hiep Nguyen, MD

271

Epidural haloperidol enhances epidural morphine analgesia: three case reports
George Colclough, Tom McLarney and Paul A. Sloan, MD

273

Clinical Trial Results: A Randomized, Double-Blind, Placebo Controlled, Trial of Three-Day Bupivacaine Transdermal Patch (ELADUR™) in Patients with Post-Herpetic Neuralgia
Mark Steven Wallace, MD, David Kudrow, MD, William McElveen, MD, Michael Drass, MD, Lynn R. Webster, MD, FACPM, FASAM, John Huddlestone, MD, Lowell Reynolds, MD, Dmitri Lissin, MD and Peter Langecker, MD

275

Pharmacokinetic Characteristics of Bupivacaine Delivered by Transdermal Patches
Jaymin Shah, Judy Johnston, Dmitri Lissin, Andy Miksztal and Suil Yum

277

A multicenter open-label long-term study of the safety of NGX-4010 for the treatment of neuropathic pain in patients with painful HIV-distal sensory polyneuropathy (HIV-DSP) or postherpetic neuralgia (PHN)
David M. Simpson, MD, Suzanne Gazda, MD, Stephen J. Brown, MD, Lynn R. Webster, MD, FACPM, FASAM, Geertrui F. Vanhove, MD, PhD, MBA, Mary Ann Sutton, Shiao-ping Lu and Jeffrey Tobias

279

Comparison of plasma pharmacokinetics of FLECTOR^® Patch (diclofenac epolamine topical patch) and oral Voltaren^® (diclofenac sodium enteric-coated tablets) in healthy volunteers
Antonio Rusca, MD, FMH, Giuseppe Mautone, MSc, Stephen Sun, MD, Merrell Magelli, PharmD and Franklin Johnson, MS

281

Abuse-deterrent properties and pharmacokinetics of a novel sustained release formulation of oxycodone for the treatment of moderate to severe pain
Alison B. Fleming, PhD, Patrick Noonan, PhD and Alistair Wheeler, MD, MFPM

283

Use of pregabalin in patients with neuropathic pain in the UK
Ariel Berger, Alesia Sadosky, Ellen Dukes and Gerry Oster

285

Costs and utilization of pharmacologic interventions for fibromyalgia and its comorbidities
Stuart Silverman, MD, Nancy Brandenberg and Lisa Mucha, PhD

287

Pregabalin (Lyrica®) treatment effects: Correlations of sleep diaries with medical outcomes sleep scale (MOS-SS) in fibromyalgia (FM) patients in two studies
I. Jon Russell, PhD, MD, L. Pauer, E. Whalen and J. Barrett, PhD

289

Fibromyalgia (FM) Patients Treated with Pregabalin (Lyrica®) Experience Improved Pain Reduction Regardless of Baseline Anxiety and Depression Levels
Lesley M. Arnold, MD, L. Pauer, E. Whalen, J. Barrett, PhD and T. Leon

291

Chronic-pain treatment with opioids: Practice does not follow policy
Nancy Alvarez, PharmD, Timothy W. Victor and Errol Gould

293

Central sensitization, chronic pain syndromes, and pregabalin
Michael Tuchman, Edith Durso-DeCruz, T.Kevin Murphy and Jeannette Barrett

295

Iliopsoas bursa injection for groin pain induced by weight loss therapy program
Matthew Johnson, DO and Patricia Nance

297

Clinical and economic outcomes of pregabalin versus controlled-release oxycodone in patients with painful diabetic polyneuropathy
Ellen Dukes, Ph, D, Montserrat Vera-Llonch, MD, MPH, Alesia Sadosky and Gerry Oster, PhD

301

Inpatient Admission for Pain Rehabilitation: Re-Examining An Old Idea
Daniel Feldman, MD, Kenneth Vitale, MD, Arthur Jimenez, MD and Paul Gusmorino, MD

303

Psychological, social and physical treatment outcomes for geriatric patients with chronic non-cancer pain at a multidisciplinary pain rehabilitation center
Kathleen Romanek Darchuk, PhD, Cynthia Townsend, PhD, Barbara Bruce, PhD, Michael Hooten, MD, John Schmidt, PhD and Jenny Kerkvliet, MA

305

A prospective analysis of acceptance of pain and values-based action in chronic pain sufferers
Kevin E. Vowles, PhD and Lance M. McCracken, PhD

307

Association of hypervigilance with perceptual and cardiovascular responses to experimental pain among African Americans and non-Hispanic Whites
Bridgett Rahim-Williams, MA, MPH, PhD, Joseph L. Riley, PhD, Claudia M. Campbell, PhD, Dyanne Herrera, BS, Barbara A. Hastie, PhD and Roger B. Fillingim, PhD

309

Personality correlates of pain and nociceptive sensitivity: The influence of Traditionalism
Carl Lattimore, Klanci M. McCabe, Amy E. Williams, Emily J. Bartley, Mary C. Chandler and Jamie L. Rhudy

311

Acceptance of pain: A preliminary study in advanced cancer patients
L.R. Gauthier, G. Rodin, C. Zimmermann, D. Warr, M. Moore, F. Shepherd and Lucia Gagliese, PhD

313

Confirmatory factor analysis of pain beliefs in significant others
Amy Loree, BA, Annmarie Cano, PhD and Lisa Renee Miller, BS

315

Effects of relaxation/music and patient teaching for pain management on salivary cortisol
Marion Good, PhD, FAAN, Gene Cranston Anderson, PhD, RN, FAAN, Stephen Wotman, DDS, Jeffrey M. Albert, PhD, Xiaomei Cong, PhD, RN, Ling-Chun Chiang, MSN, RN and Esther Bernhofer, RN

317

Assessing emotional processing in persons with fibromyalgia: Emotional picture-viewing and the acoustic startle reflex
Emily J. Bartley, MS, Amy E. Williams, MA and Jamie L. Rhudy, PhD

319

Catastrophizing and Interleukin-6 Reactivity to Pain
Robert Edwards, PhD

325

Comparison of adaptive and maladaptive coping/appraisal as they relate to adjustment to chronic pain
Gabriel Tan, PhD, ABPP and Mark P. Jensen, PhD

327

Pain catastrophizing, but not fear of pain, mediates the relation between strenuous exercise involvement and pain response: The moderating role of anxiety sensitivity
Burel Goodin, MA and Lynanne McGuire, PhD

329

Preference of Social Support Types and Differential Effects of Pain Controllability, Perceived Social Support, and Disparity in Social Support on Depression and Adjustment
Sungkun Cho, Puihan J. Chao, Ira D. Zunin, James Mckoy and Elaine M. Heiby

331

Maintenance of pain self-management behaviors after treatment in interdisciplinary pain treatment
Joseph E. Wallach, MA, Robert Schleser, PhD, Gila I. Wallach, MS and R. Norman Harden, MD

333

Older adults' response to health care practitioner pain communication
Deborah Dillon McDonald, RN, PhD, Maura Shea, Leonie Rose and John Fedo

335

The Effects of Neuroticism, Pain Catastrophizing, and Disparity in Emotional Support on Depression, Pain Intensity, and Adjustment: A Structural Equations Approach
Sungkun Cho, Puihan J. Chao, Ira D. Zunin, James Mckoy and Elaine M. Heiby

337

Marital satisfaction and depression: Preliminary results of the role of empathic accuracy
Michelle T. Leonard, MA, Jaclyn Heller and Annmarie Cano

339

Chronic pain and health-related quality of life in Croatian war veterans
Marijana Bras, Zoran Loncar, Lovorka Brajkovic, Inja Erceg and Rudolf Gregurek

341

Treatment Outcomes of a Multidisciplinary Chronic Nonmalignant Pain Rehabilitation Program: The Examination of Differences between Patients Based on Disability Income Status
Lisa L. Ferguson, BS, Laura Burns, PhD, Judith Scheman, PhD and Edward Covington, MD

343

Adolescent and parent pain beliefs and readiness to change in the context of an initial multidisciplinary pain clinic consultation: Preliminary findings
Jessica W. Guite, PhD, Jennifer Sherker, PsyD, Stephanie V. Hernandez, BA, David D. Sherry, MD and John B. Rose, MD

345

Taste perception related to pain responses among African Americans and non-Hispanic whites
Dyanne Herrera, Claudia M. Campbell, PhD, Christopher France, PhD, Linda Bartoshuk, PhD and Roger B. Fillingim, PhD

347

Diffuse Noxious Inhibitory Controls (DNIC) in African Americans, Asian Americans and non-Hispanic whites
Claudia M. Campbell, PhD

349

Sex and race differences in rating others' pain, pain-related negative mood, pain coping, and need for medical treatment
Michael E. Robinson, PhD, Ashraf Alqudah, PhD, Adam Hirsh, MS and Lauren Stutts, MS

351

Who completes an interdisciplinary pain program? Identifying potential barriers to completion of treatment
Sarah R. Oslund, Richard C. Robinson, PhD, Timothy S. Clark, PhD, Carl E. Noe, MD and John Garofalo, PhD

353

Supporting self management groups by way of videoconference: a case study
Denis J. Martin, Director

355

Validation of a self-report version of the Child Activity Limitations Interview (CALI)
Amy S. Lewandowski, MA, Anna C. Long, PhD and Tonya M. Palermo, PhD

357

A review of the current status of measurement of the impact of adolescent chronic pain
Abbie Jordan, PhD and Christopher Eccleston, PhD

359

Children's Computer Assessment of Pain and Mood
Gilbert J. Fanciullo, MD, Padma Gulur, MD, Tabitha A. Washington, MD, Bridget O. Mudge, MS, Gregory J. McHugo, PhD and John C. Baird, PhD

361

Three-dimensional pain mapping
Tabitha A. Washington, MD, Padma Gulur, MD, Gilbert J. Fanciullo, MD, Robert Jamison, PhD, Gregory J. McHugo, PhD and John C. Baird, PhD

363

Ask Me Where it Hurts?: Using an Electronic Pain Diary to Better Understand Pain in Adolescents with Arthritis
Jennifer N. Stinson, RN, PhD, CPNP, Bonnie Stevens, RN, PhD, Brian Feldman, MD, FRCPC, David Streiner, PhD, CPsych, Patrick McGrath, OC, PhD, Annie Dupuis, PhD, Navreet Gill, RN, BSc and Guy Petroz, MD

365

MCMI-III as a method to compare the prevalence of psychiatric disorders in patients with chronic pain
Rob Haggard, MS, CRC, Anna W. Stowell, PhD, Robert Gatchel, PhD, ABPP, Dana Bernstein, PhD, Tommy Overman, EdD, Francis McManemin, Ph.D., C.E. McCoy, Ph.D. and Greg Garland

367

Evaluation and treatment of a heterogeneous group of chronic pain patients: Assessing the effect size of outcome measures
Whitney Worzer, MS, CRC, Anna W. Stowell, PhD, Dana Bernstein, PhD and Robert Gatchel, PhD, ABPP

369

Pain Outcomes Evaluation Tool (POET) – Preliminary opioid suitability screening data electronically acquired at an academic tertiary care pain center
Gilbert J. Fanciullo, MD, MS, Julie Sorenson, MD, MPH, Tabitha Washington, MD, MS, Ralph Beasley, MD, Devi Nampiaparampil, MD and Stephanie L. Singleton

371

Efficacy of an interdisciplinary pain management program with workers compensation patients
Christine M. Gagnon, Steven Stanos, DO, Geke Van der Ende, Lynn Rader, MD and R. Norman Harden, MD

373

Unmet needs among patients experiencing acute and chronic pain: Results from a survey of 606 pain patients and 491 physicians
Pamela Vo, Steven Marx and Leslie Penles

375

Electronic Medical Records: Application to the Pain Epidemiology
Ratan K. Banik

377

Chronic pain prevalence in Michigan
Lisa Renee Miller, BS and Annmarie Cano, PhD

379

Time trade-off derived health utilities: Assessing the burden of chronic pain
Tunisia Finch, Laura DeLong, MD, MPH, Michael Schaufele, MD, Livia Van, Seema Kini, Shinko Lin, Ricardo Berrios, Alice Huang, Anne Marie McKenzie-Brown, MD, Suephy Chen, MD, MS and Mary Jayne McIlwain

381

Neighborhood SES, race, education, and chronic pain in working aged blacks and whites
Tamera Hart-Johnson, MS and Carmen Green, MD

383

Variables affecting pain communication
Maura Lu Shea, RN, MS, CCRN and Deborah Dillon McDonald, RN, PhD

385

Anxiety sensitivity, catastrophizing, and the experience of pain in children
Jennie C.I. Tsao, PhD, Qian Lu, MD, PhD, Subhadra Evans, Su Kim, MA, Cynthia D. Myers, PhD, LMT and Lonnie Zeltzer, MD

387

Barriers to pain management among adolescents with cancer
Suzanne Ameringer, PhD, RN, Sandra Ward, PhD and Susan Hughes, MS, RN

389

Using cognitive interviews to assess the usefulness of Hmong language versions of two pain assessment tools
Karl E. Johnson, MA, June L. Dahl, PhD, Karen M. Stevenson, RN, MSN, Marty Skemp-Brown, MBA, Debra B. Gordon, RN, MS, FAAN and Sandra Ward, PhD

391

Initial Development of a Multidimensional Pain Item Bank for Geriatric Oncology Patients
Chih-Hung Chang, PhD and Theresa Kowalski, AB

393

Do children with sickle cell pain receive disparate care in the emergency department?
William T. Zempsky, MD, Kristin Loiselle, BS, Brian H. Lee, J. Nathan Hagstrom, MD and Neil L. Schechter, MD

395

What clinical domains should be assessed in a computerized clinical advisory system for pain treatment?
Simon Budman, Katherine Lioy, Elizabeth Donovan, Pravin Pant, Stephen Butler and Robert Jamison, PhD

397

Relationships of job accommodations, stressors, and sources of support for employed chronic pain patients with job satisfaction.
Melinda L. Scheuer, MS, Christine M. Gagnon, PhD, Geke Van der Ende, MS, Michael Gallizzi, MS, Lynn Rader, MD, Steven Stanos, DO and R. Norman Harden, MD

399

Low-Dose Ketamine for Vasoocclusive Pain in Pediatric Patients with Sickle Cell Disease: A Case Series
William T. Zempsky, MD, Kristin A. Loiselle, BS, J. Nathan Hagstrom, MD and Zeev N. Kain, MD, MBA

401

The Pain Improvement Partnership Program: Status of pain care in long-term care
Karen M. Stevenson, MS, RN and June L. Dahl, PhD

403

Knowledge, experience, and beliefs about pain and analgesia: Results of a general household survey in Texas
Scott A. Strassels, PharmD, PhD, Helen Ross Petty, Karen Torges and Larry Driver, MD

405

Knowledge, attitudes and practices of Texas physicians may contribute to inadequate pain care
Scott A. Strassels, PharmD, PhD, Helen Ross Petty, Karen Torges and Larry Driver, MD

407

Low back pain management with the workplace: An assessment of barriers and facilitators
Jean-Baptiste Fassier, Marie-José Durand and Patrick Loisel

409

Breaking the Myth of Malingering in Chronic Pain Sufferers
Kristynia M. Robinson, PhD, FNP, RN and Jose J. Monsivais, MD

411

Viral spread of prescription opioid administration techniques via Internet message boards
Stephen F. Butler, PhD, James Dickinson, Christine Benoit and Simon Budman

413

Neuroimaging the brain in pain: Medical disability, tort law, and an ethical evaluation
David V. Yokum, BS

American Pain Society's 27th Annual Scientific Meeting (May 8 – 10, 2008): Poster Session I

P1 Poster Session I